Navigation Links
Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis

sma-derived protein market is estimated to reach US$8.5 billion by 2010. The North American market was estimated at US$2.4 billion in 2006. Immunoglobulin is the biggest selling protein in North America, with sales estimated at US$1.4 billion in 2006 in the United States alone. Immunoglobulin is used to treat immunological, neurological and other disorders. Plasminogen, once converted into plasmin, is a clot buster and offers a natural alternative to synthesized solutions to address an unmet need of the market. A1PI is used by patients suffering from hereditary emphysema resulting from A1PI deficiency. A1PI deficiency affects between 60,000 to 100,000 people in the United States.

According to Cowen and Company, enzyme replacement therapies (ERTs) will reach US$3.1B in 2011. ERTs are the cornerstone of treatment of many orphan disorders, particularly the lysosomal storage diseases. Orphan diseases are comprised of number different conditions that each afflict only a small number of individuals, but together constitute one of the most lucrative therapeutic areas. The four leading lysosomal disorder products are intended to treat Gaucher's disease, Fabry's disease, Hurler's disease and Pompe's disease.

In 2006, estimated sales for these four leading lysosomal disorder products were US$1 billion, US$359 million, US$96 million and US$30 million respectively, nearly US$1.5 billion in total. Haemacure has identified in its plasma discard enzymes each treating one of these diseases. The enzymes are alpha-galactosidase, used to treat Fabry's disease, alpha-glucosidase, used to treat Pompe's disease, beta-glucosidase, used to treat Gaucher's disease, and alpha-iduronidase, used to treat Hurler's disease.

Haemacure has also identified three other enzymes, used to treat Hunter's disease, Morquio's disease and Shindler's disease. Products are also in development for these diseases.

As advised, these findings are preliminary and the full value of these
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:5/4/2015)... 2015  Impax Laboratories, Inc. (NASDAQ: IPXL ) ... roles, appointing  Donna M. Hughes, as Senior Vice President, ... Senior Vice President, Chief Compliance Officer. Both Ms. Hughes ... Chief Executive Officer, Fred Wilkinson . ... the Impax team," said Fred Wilkinson , President ...
(Date:5/4/2015)...  Makindus, Inc. a specialty pharmaceutical development company focused ... (EMA) has granted orphan drug designation for their lead ... "We are extremely pleased to now have orphan ... place for Europe . This complements ... United States for which orphan designation has ...
(Date:5/4/2015)... , May 4, 2015  By looking ... possible to distinguish between two very different conditions ... Theodore Henderson , MD, PhD., a ... complex cases, this study can help ... and therefore treatment options, for Post-Traumatic Stress Disorder ...
Breaking Medicine Technology:Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 2Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance 3European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 3
... DIEGO, Dec. 1 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ... completed preclinical study has affirmed the bioequivalence and comparable ... Pharmaceuticals, ADVENTRX,s partner for ANX-514 in South Korea, independently ... "Our independent confirmation of the bioequivalence and comparable overall ...
... , REDWOOD CITY, Calif., Dec. 1 Codexis, Inc. today ... its second agreement this year with Teva Pharmaceutical Industries Ltd., ... covers three undisclosed pharmaceutical products. Codexis announced an earlier ... agreement, Teva will use Codexis biocatalysis technology for key process ...
Cached Medicine Technology:ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3Codexis Expands Collaboration with Teva 2
(Date:5/5/2015)... BioFit Engineered Products , a ... models from its two latest lines at NeoCon 2015, ... Chicago. Headlining the company’s exhibit will be new Pro ... as well as the unveiling of the fifth model ... Ed Metzger will deliver in-booth presentations each day of ...
(Date:5/5/2015)... NY (PRWEB) May 05, 2015 With the ... clothing and enjoying the feel of warm breezes on bare ... to strategies on how to look their best in shorts, ... “More and more people are turning to laser treatments for ... aesthetician of Simply Posh Aesthetic Spa . “They're all ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 “We currently have larger ... states Marta Phillips, owner of SunGrubbies.com. “We felt it was ... to find a fashionable sun hat in an extra large size ... event.” , Fashionable derby sun hats such as the ... brim are now available in an extra large size , ...
(Date:5/5/2015)... San Francisco, Calif. (PRWEB) May 05, 2015 ... available online but these have focused primarily on personal ... the National Directory of Insurance (NDOI.com) has ... licensed insurance agents in the U.S. to present their ... public marketplace. , The result is significant and two-fold. ...
(Date:5/5/2015)... York, NY (PRWEB) May 05, 2015 No ... The Centers for Disease Control and Prevention cite ... effects our everyday life: “Poor indoor air quality (pollution) can ... to chronic heart and lung problems and cancer.” , Toxic ... swallow them in contaminated food or water, or in some ...
Breaking Medicine News(10 mins):Health News:BioFit to Introduce New Models from Latest Specialized Ergonomic Seating Lines at NeoCon 2015 2Health News:BioFit to Introduce New Models from Latest Specialized Ergonomic Seating Lines at NeoCon 2015 3Health News:Laser Hair Removal: Tips for Summertime Grooming 2Health News:Laser Hair Removal: Tips for Summertime Grooming 3Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Launches Their New Extra Large Size Fashion Sun Hats Collection 2Health News:NDOI Launch Brings Commercial Insurance Online for the First Time 2Health News:NDOI Launch Brings Commercial Insurance Online for the First Time 3Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 3
... to reasearchers, a hormone is released into the blood after ... might be supportive in treating obesity. The reason for feeling ... hormone called PYY3-36 //which acts on the brain to produce ... report on the first human trial of PYY3-36. ...
... could be saved each year, if only everyone over the ... experts, Dr. Gregory Poland fe that universal vaccination in three ... by 40 to 50 per cent. Clearly vaccination can be ... per cent. ,Dr Poland proposes some changes to ...
... to the dimpled, 'orange peel' skin on the thighs, buttocks, ... all have a beneficial effect on the appearance of cellulite ... body's natural way of storing fat in women and occurs ... a dermatologist at the University of California, cellulite is now ...
... According to recent update, people with type 2 diabetes ... able to safely reduce their risk for heart disease ... runs counter to previous research, which showed niacin adversely ... the researchers used high doses of the medication. ...
... in lessening the symptoms of fibromyalgia.,Researchers at Pole Hospital, ... with fibromyalgia, a painful muscular condition whose causes are ... to routine sessions of graded aerobic exercise, supervised by ... of those in the exercise group rated themselves as ...
... feel, that we need to learn more about ... microwaves play an increasing role in everyday life - ... pagers, and text messengers. ,We often walk past ... other words, we are bathed in an invisible 'electrosmog', ...
Cached Medicine News:
Coat-A-Count PSA IRMA is an,immunoradiometric assay intended for the,quantitative measurement of,prostate-specific antigen (PSA) in serum,to aid in the management of prostate,cancer patient...
Stereo Smile II also includes a blank card and tests,at 60, 120, 240 and 480 sec of arc., ,Smile Test II Includes:, 1 demonstration card, 1 pair pediatric 3-D viewers, 1 pair infant 3-D v...
... and Evaluate Stereo Depth Perception ... 250 sec of arc). , ... Test (400 to 20 sec ... for Children (400 to 100 ...
The Emit 2000 Phenytoin Assay is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of phenytoin in human serum or plasma. Emit 2000 assays are designed for use with most ...
Medicine Products: